Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Ernexa Therapeutics Inc. (NASDAQ : ERNA) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
Quote
| Last: | $5.90 |
|---|---|
| Change Percent: | -5.75% |
| Open: | $6.26 |
| Close: | $6.26 |
| High: | $6.26 |
| Low: | $5.79 |
| Volume: | 22,527 |
| Last Trade Date Time: | 06/22/2026 12:45:50 pm |
Stock Data
| Market Cap: | $2,395,329 |
|---|---|
| Float: | 2,930,155 |
| Insiders Ownership: | N/A |
| Institutions: | 11 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.ernexatx.com |
| Country: | US |
| City: | Cambridge |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Ernexa Therapeutics Inc. (NASDAQ: ERNA).
